Evidence map›Paper›PMID 36132929›Full record

ReviewNanoscale advances2020

Microneedle-based bioassays.

Jixiang Zhu, Xingwu Zhou, Alberto Libanori, Wujin Sun

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nanoscale advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. A Bioinspired and Cost-Effective Device for Minimally Invasive Blood Sampling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  5. Article
  6. Nanoscale advances · 2023
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Jixiang ZhuDepartment of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles Los Angeles CA 90095 USA sunwj@ucla.edu.
Xingwu ZhouDepartment of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles Los Angeles CA 90095 USA sunwj@ucla.edu.
Alberto LibanoriDepartment of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles Los Angeles CA 90095 USA sunwj@ucla.edu.ORCID https://orcid.org/0000-0003-1913-3017
Wujin SunDepartment of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles Los Angeles CA 90095 USA sunwj@ucla.edu.ORCID https://orcid.org/0000-0002-3167-111X
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disease diagnosis and therapeutic efficacy can be monitored

Identifiers

PMID36132929
PMCPMC9419780
OpenAlexW3093326622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.